Profile cover photo
Profile photo
Translational Research in Oncology (TRIO)
15 followers -
TRIO: a leader in personalized therapy, the future of oncology.
TRIO: a leader in personalized therapy, the future of oncology.

15 followers
About
Posts

Post has attachment

Post has attachment
September 24th is World Cancer Research Day.
Add a comment...

Post has attachment

Post has attachment
More great work being done by the TRIO team and our investigators.
Add a comment...

Post has attachment
Health Canada Approves New First-Line Treatment for Women Living with Metastatic Breast Cancer

Be sure to watch this interview with TRIO's Executive Director, Dr. John Mackey, on the announcement:

http://www.multivu.com/players/English/7828151-ibrance/
Add a comment...

Post has attachment

Post has attachment

Post has attachment
Pfizer Announces Positive Top-Line Results for Phase 3 PALOMA-2 Clinical Trial of IBRANCE® (palbociclib). Another exciting advancement in breast cancer research. Catch the full press release here:

http://www.businesswire.com/news/home/20160419005882/en/Pfizer-Announces-Positive-Top-Line-Results-Phase-3#.VxajRfFw6ik.email
Add a comment...

Post has attachment
A recently published study from a University of Alberta doctor has shown that "bad cholesterol” medication may inhibit the growth of cancerous tumours. TRIO’s Executive Director Dr. John Mackey comments on the next steps. Check out the full article here:
 
http://www.cbc.ca/news/canada/edmonton/university-of-alberta-study-shows-that-cholesterol-medication-may-slow-tumour-growth-1.3530998
Add a comment...

Post has attachment
Help Kimberley keep running! Support cancer research today!

https://youtu.be/Yc1BqUCJt68
Add a comment...
Wait while more posts are being loaded